Cargando…
The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase
The RNA-guided Cas9 nuclease, from the type II prokaryotic clustered regularly interspersed short palindromic repeats (CRISPR) adaptive immune system, has been adapted by scientists to enable site specific genome editing of eukaryotic cells both in vitro and in vivo. Previously, we reported the deve...
Autores principales: | Kumar, Namrata, Stanford, William, de Solis, Christopher, Aradhana, Abraham, Nigel D., Dao, Trieu-Mi J., Thaseen, Sadiqa, Sairavi, Anusha, Gonzalez, Cuauhtemoc Ulises, Ploski, Jonathan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243075/ https://www.ncbi.nlm.nih.gov/pubmed/30483052 http://dx.doi.org/10.3389/fnmol.2018.00413 |
Ejemplares similares
-
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018) -
Improvement of muscular atrophy by AAV–SaCas9-mediated myostatin gene editing in aged mice
por: Weng, Shaoting, et al.
Publicado: (2020) -
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
por: Vizoso, Miguel, et al.
Publicado: (2022) -
Construction of a rAAV-SaCas9 system expressing eGFP and its application to improve muscle mass
por: Weng, Shaoting, et al.
Publicado: (2021) -
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters
por: Yan, Kun, et al.
Publicado: (2021)